Merck to acquire Verona Pharma for US$ 10 billion
Acquisition aligns with Merck’s science-led business development strategy and expands pipeline and portfolio of treatments for cardio-pulmonary diseases
Acquisition aligns with Merck’s science-led business development strategy and expands pipeline and portfolio of treatments for cardio-pulmonary diseases
Acquisition to be followed by merger; strengthens Torrent’s IPM market presence
The company has been awarded a contract for the supply of essential pharmaceutical formulations to government health institutions across Rajasthan
The transaction is expected to close in Q2 FY 2026
Dilip Shanghvi to continue as the Executive Chairman of the Board
Adds fast-growing and only approved medicine for advanced and indolent systemic mastocytosis to the Sanofi portfolio
The company also announced results for the third quarter, reporting sales at Rs. 992 crore, flat versus year ago
Scores highest PAT of Rs. 118 crore in FY25
Subscribe To Our Newsletter & Stay Updated